(Q44582234)

English

Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer

scientific article published on 2 October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

Masaki Mori

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

11

object named as

Yuichiro Doki

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yukinori Kurokawa

9

object named as

Yukinori Kurokawa

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shuji Takiguchi

5

object named as

Shuji Takiguchi

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kiyokazu Nakajima

6

object named as

Kiyokazu Nakajima

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

7

object named as

Hiroshi Miyata

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Kaoru Okada

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yoshiyuki Fujiwara

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tsuyoshi Takahashi

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yurika Nakamura

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Makoto Yamasaki

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

2 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1035-1043

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1 is required for execution of the mitotic programme and chromosome stability

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1: a master regulator of tumor metastasis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1 mediates resistance to herceptin and paclitaxel.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FOXM1 confers acquired cisplatin resistance in breast cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2680-0

21 January 2018

Identifiers

10.1245/S10434-012-2680-0

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44582234&oldid=2206760715"